Canada

Onconic Therapeutics Unveils Pancreatic Cancer Trial Data at ASCO, Patient Survives Over 40 Months – FirstWord Pharma

6 days ago
0 Views
1 Min Read
  1. Onconic Therapeutics Unveils Pancreatic Cancer Trial Data at ASCO, Patient Survives Over 40 Months  FirstWord Pharma
  2. ‘Game changer’ experimental drug doubles survival time for pancreatic cancer, trial shows  CBC
  3. ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long  The Washington Post
  4. Daily pill doubles survival time for pancreatic cancer patients  BBC
  5. Promising new treatment for pancreatic cancer doubles survival rates  PBS

Add Comment

Click here to post a comment